A track record of innovation.
scPharmaceuticals was formed in 2013 with the intent to advance outpatient care and reduce healthcare costs.
Through ongoing exploration across a range of therapeutic areas and related treatment paradigms, we have successfully produced advanced drug formulations, innovative delivery systems, and other complementary solutions. Our lead program, a proprietary formulation of a diuretic for subcutaneous administration is under development for the treatment of congestion in patients with heart failure who display a reduced responsiveness to oral diuretics and who do not require hospitalization.
Our follow-up programs are focused on subcutaneous administration of select antibacterial agents that have the potential to allow at-home treatment without the need for long-term intravenous catheters.